Anti-inflammatory actions of flavonoids and structural requirements for new design

Chemistry and Molecular Aspects of Drug Design and Action

Volumn , Issue , 2008, Pages 215-226

  Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84966431895     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420008272     Document Type: Chapter

References (60)

1. Middleton, E., Jr., Kandaswami, C., and Theoharides, T.C., The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer, Pharmacol. Rev., 52, 673, 2000.
2. Wang, H.K., The therapeutic potential of flavonoids, Exp. Opin. Invest. Drugs., 9, 2103, 2000.
3. Middleton, E., Jr., The flavonoids, Trends Pharm. Sci., 5, 335, 1984.
4. Middleton, E., Jr. and Kandaswami, C., Effects of flavonoids on immune and inflammatory cell functions, Biochem. Pharmacol., 43, 1167, 1992.
5. Rodewald, H.R. et al., Identification of a committed precursor for the mast cell lineage, Science, 271, 818, 1996.
6. Galli, S.J., New concepts about the mast cell, N. Engl. J. Med., 328, 257, 1993.
7. Schwartz, L.B., Mediators of human mast cells and human mast cell subsets, Ann. Allergy, 58, 226, 1987.
8. Serafin, W.E. and Austen, K.F., Mediators of immediate hypersensitivity reactions, N. Engl. J. Med., 317, 30, 1987.
9. Grabbe, J. et al., Comparative cytokine release from human monocytes, monocytederived immature mast cells and a human mast cell line (HMC-1), J. Invest. Dermatol., 103, 504, 1994.
10. Theoharides, T.C. et al., Differential release of serotonin and histamine from mast cells, Nature, 297, 229, 1982.
11. Theoharides, T.C. and Douglas, W.W., Secretion in mast cells induced by calcium entrapped within phospholipid vesicles, Science, 201, 1143, 1978.
12. Benyon, R., Robinson, C., and Church, M.K., Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli, Br. J. Pharmacol., 97, 898, 1989.
13. Gagari, E. et al., Differential release of mast cell interleukin-6 via c-kit, Blood, 89, 2654, 1997.
14. Theoharides, T.C., Mast cell: a neuroimmunoendocrine master player, Int. J. Tissue React., 18, 1, 1996.
15. Mekori, Y.A. and Metcalfe, D.D., Mast cells in innate immunity, Immunol. Rev., 173, 131, 2000.
16. Marone, G. et al., Molecular and cellular biology of mast cells and basophils, Int. Arch. Allergy Immunol., 114, 207, 1997.
17. Wedemeyer, J., Tsai, M., and Galli, S.J., Roles of mast cells and basophils in innate and acquired immunity, Curr. Opin. Immunol., 12, 624, 2000.
18. Kay, A.B., Allergy and allergic diseases: First of two parts, N. Engl. J. Med., 344, 30, 2001.
19. Kay, A.B., Allergy and allergic diseases: Second of two parts, N. Engl. J. Med., 344, 109, 2001.
20. Kimata, M., Inagaki, N., and Nagai, H., Effects of luteolin and other flavonoids on IgEmediated allergic reactions, Planta Medica, 66, 25, 2000.
21. Kimata, M. et al., Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells, Clin. Exp. Allergy, 30, 501, 1999.
22. ++ influx and exocytosis in rat peritoneal mast cells, Biochim. Biophys. Acta., 469, 52, 1977.
23. Middleton, E. and Drzewiecki, G., Flavonoid inhibition of human basophil histamine release stimulated by various agents, Pharmacology, 33, 3333, 1984.
24. Trnovsky, J. et al., Quercetin-induced expression of rat mast cell protease II and accumulation of secretory granules in rat basophilic leukemia cells, Biochem. Pharmacol., 46, 2315, 1993.
25. Kempuraj, D., Madhappan, B., Christodoulou, S., Boucher, W., Papadopoulou, N., Cetrulo, C.L., and Theoharides, T.C., Flavonols inhibit pro-inflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol., 145, 934-944, 2005.
26. Sieghart, W. et al., Calcium-dependent protein phosphorylation during secretion by exocytosis in the mast cell, Nature, 275, 329, 1978.
27. Theoharides, T.C. et al., Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein, Science, 207, 80, 1980.
28. Sieghart, W. et al., Phosphorylation of a single mast cell protein in response to drugs that inhibit secretion, Biochem. Pharmacol., 30, 2737, 1981.
29. Correia, I. et al., Characterization of the 78 kDa mast cell protein phosphorylated by the antiallergic drug cromolyn and homology to moesin, Biochem. Pharmacol., 52, 413, 1996.
30. Lankes, W.T. and Furthmayr, H., Moesin: a member of the protein 4.1-talin-ezrin family of proteins, Proc. Natl. Acad. Sci. U.S.A., 88, 8297, 1991.
31. Tsukita, S. and Yonemura, S., ERM (ezrin/radixin/moesin) family: From cytoskeleton to signal transduction, Curr. Opin. Cell Biol., 9, 70, 1997.
32. 2+ and phorbol ester effect on the mast cell phosphoprotein induced by cromolyn, Eur. J. Pharmacol., 371, 241, 1999.
33. Theoharides, T.C. et al., Cloning and cellular localization of the rat mast cell 78kD protein phosphorylated in response to the mast cell “stabilizer” cromolyn, J. Pharmacol. Exp. Ther., 294, 810, 2000.
34. Fewtrell, C.M. and Gomperts, B.D., Effect of flavone inhibitors of transport ATPases on histamine secretion from rat mast cells, Nature, 265, 635, 1977.
35. Pearce, F.L., Befus, A.D., and Bienenstock, J., Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells, J. Allergy Clin. Immunol., 73, 819, 1984.
36. Barrett, K.E. and Metcalfe, D.D., The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: effects of secretagogues and anti-allergic drugs on histamine secretion, J. Immunol., 135, 2020, 1985.
37. Fox, C.C. et al., Comparison of human lung and intestinal mast cells, J. Allergy Clin. Immunol., 81, 89, 1988.
38. Berton, G., Schneider, C., and Romeo, D., Inhibition by quercetin of activation of polymorphonuclear leucocyte functions, Biochim. Biophys. Acta., 595, 47, 1980.
39. Devi, M.A. and Das, N.P., In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2, Cancer Lett., 69, 191, 1993.
40. Namgoong, S.Y. et al., Effects of naturally occurring flavonoids on mitogen-induced lymphocyte proliferation and mixed lymphocyte cuture, Life Sci., 54, 313, 1993.
41. Scambia, G. et al., Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids, Int. J. Cancer, 46, 1112, 1990.
42. Pick, M. et al., Flavonoid modulation of protein kinase C activation, Life Sci., 44, 1563, 1989.
43. Ferriola, P.C., Cody, V., and Middleton, E., Protein kinase inhibition by plant flavonoids, kinetic mechanisms and structure-activity relationships, Biochem. Pharmacol., 38, 1617, 1989.
44. Nishizuka, Y., The molecular heterogeneity of protein kinase C and its implications for cellular regulation, Nature, 334, 661, 1988.
45. Kandere-Grzybowska, K., Kempouraj, S., Cao, J., and Theoharides, T.C., Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br. J. Pharmacol., 148, 208-215, 2006.
46. Seldin, D.C. et al., Homology of the rat basophilic leukemia cell and the rat mucosal mast cell, Proc. Natl. Acad. Sci. U.S.A., 82, 3871, 1985.
47. Oliver, J.M. et al., Signal transduction and cellular response in RBL-2H3 mast cells, Prog. Allergy, 42, 185, 1988.
48. i GTP-binding proteins linked to a phospholipase C signaling pathway, J. Immunol., 160, 5136, 1998.
49. Karimi, K. et al., Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P, Exp. Hematol., 28, 626, 2000.
50. Larocca, L.M. et al., Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors, Br. J. Haematol., 79, 562, 1991.
51. Kang, T. and Liang, N., Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells, Biochem. Pharmacol., 54, 1013, 1997.
52. Mitsumori, Y. et al., The effect of quercetin on cell cycle progression and growth of human gastric cancer cells, FEBS Lett., 260, 10, 1990.
53. Damianaki, A. et al., Potent inhibitory action of red wine polyphenols on human breast cancer cells, J. Cell. Biochem., 78, 429, 2000.
54. Pang, X. et al., Bladder mast cell expression of high affinity estrogen receptors in patients with interstitial cystitis, Br. J. Urol., 75, 154, 1995.
55. Longley, J., Duffy, T.P., and Kohn, S., The mast cell and mast cell disease, J. Am. Acad. Dermatol., 32, 545, 1995.
56. Theoharides, T.C. et al., Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study, J. Urol., 153, 629, 1995.
57. Granerus, G., Lönnqvist, B., and Roupe, G., No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis, Agents Actions, 41, C127, 1994.
58. Theoharides, T.C. et al., Chondroitin sulfate inhibits connective tissue mast cells, Br. J. Pharmacol., 131, 10139, 2000.
59. Krilis, S.A. et al., Continuous release of secretory granule proteoglycans from a strain derived from the bone marrow of a patient with diffuse cutaneous mastocytosis, Blood, 79, 144, 1992.
60. Nilsson, G. et al., Stem cell factor-dependent human cord blood derived mast cells express alpha-and beta-tryptase, heparin and chondroitin sulphate, Immunology, 88, 308, 1996.